CRH posted Q2 2026 net income of $1.5 billion, up 13% year over year; diluted EPS rose 14% to $2.21.
Revenue climbed 6% to $10.8 billion; net income margin widened 0.9 percentage point to 14.0%.
Non-GAAP adjusted EBITDA increased 7% to $2.6 billion, lifting the margin 0.3 percentage point to 24.4%.
Agreed to buy Arcosa for $150 per share in cash, valuing the deal at about $8.5 billion; closing targeted for Q1 2027.
Reaffirmed 2026 guidance for net income of $3.9 billion-$4.1 billion, non-GAAP adjusted EBITDA of $8.1 billion-$8.5 billion, diluted EPS of $5.60-$6.05.
CRH•
